APOE and Alzheimer disease: In the whole cohort, patients with AD exhibited a 1.1-fold increase in plasma total cholesterol compared to controls (p = 0.016) and MCI patients (p = 0.004), with the latter significance remaining when controlling for APOE genotype (p = 0.013).